China Eager To Establish Pharmacovigilance System – SFDA Officials
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - In an effort to ensure drug safety, China will establish a pharmacovigilance system and will continue to improve its adverse drug reaction reports system, said Yan Ming, director of the drug re-evaluation division under China's State FDA drug safety and inspection department, during an international conference on post-market drug safety Oct. 29 in Shanghai